Rehabilitation For Acquired Visual Field Defects: Development Of A Bottom-Up Approach

NCT ID: NCT01730560

Last Updated: 2025-09-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

22 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-11-29

Study Completion Date

2018-06-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cortical Visual Field Defects (CFVD) are common after acquired brain injury. They often cause problems with reading and visual exploration which impact on patients' quality of life. Apart from the substitutive method that uses prisms directly placed on glasses, two main rehabilitative methods have been explored previously: one restorative and one compensatory. The most effective methods seem to be based on compensatory training paradigms that target eye movements. They rely on voluntary mass-practice that induces changes in exploratory saccadic behaviour, particularly into the blind hemifield. Previous studies using this method have shown changes in visual scanning patterns but with only a marginal profit in terms of functional benefit.

In the present study, the investigators developed a new approach to the compensatory visual field training based solely on a bottom-up mechanism. It does not require the patients' ability to voluntarily maintain attention oriented to the affected field, which may be difficult for brain-damaged patients. As previously reported in other pathological contexts (e.g. use of prism adaptation or sensory stimulation in neglect patients), bypassing voluntary and conscious implication of the patient can produce improvements by a more automatic process.

The investigators hypotheses are: 1) that a novel ramp-step search paradigm can be used by hemianopic patients to automatically improve targeted eye movements into their blind visual field; and 2) that this will lead to behavioural improvements on ecologically valid tests of visual search.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acquired Visual Field Defects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arm 1:Treatment A

Treatment A (active) followed by treatment B (neutral)

Group Type EXPERIMENTAL

Treatment A

Intervention Type OTHER

The computer-based training task consists of a novel ramp-step search paradigm with a stimulus traversing the screen from left to right or right to left. Subjects are asked to pursue the stimulus (ramp phase) and then saccade to find its location when it suddenly jumps (step phase). The stimulus is an open spinning circle. At the end of each movement, the gap can be located at the top or at the bottom, and patients are asked to indicate this location by pushing the response button as quickly as possible.

The starting point will alternate between left and right. The training task includes 3 sessions with 100 movements each. Reaction Times and errors will be monitored online to ensure that the patient performs the task correctly.

Each treatment phase has the same pattern:

* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).

Arm 2: Treatment B

Treatment B (neutral) followed by treatment A (active)

Group Type EXPERIMENTAL

Treatment B

Intervention Type OTHER

Placebo treatment using the same computer-based training task, but including only the ramp phase.

Each treatment phase has the same pattern:

* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Treatment A

The computer-based training task consists of a novel ramp-step search paradigm with a stimulus traversing the screen from left to right or right to left. Subjects are asked to pursue the stimulus (ramp phase) and then saccade to find its location when it suddenly jumps (step phase). The stimulus is an open spinning circle. At the end of each movement, the gap can be located at the top or at the bottom, and patients are asked to indicate this location by pushing the response button as quickly as possible.

The starting point will alternate between left and right. The training task includes 3 sessions with 100 movements each. Reaction Times and errors will be monitored online to ensure that the patient performs the task correctly.

Each treatment phase has the same pattern:

* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).

Intervention Type OTHER

Treatment B

Placebo treatment using the same computer-based training task, but including only the ramp phase.

Each treatment phase has the same pattern:

* two visits in pre-tests evaluation (V1 and V2),
* one visit to perform treatment (A or B) and to assess immediate and 2h post-effects (V3),
* two visits after treatment (V4 at one week and V5 at one month).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male/Female
* Stroke (ischemia or hemorrhage) documented by CTscan or MRI
* Traumatic brain injury (TBI) documented by CTscan or MRI
* Right or Left hemianopia defined by perimetry
* All subjects must be between the ages of 18-80
* Aetiology of visual field defect : Stroke (ischemia or hemorrhage)
* Delay post-stroke : at least 6 months
* Only one lesion on CTscan or MRI (performed in a maximal delay of 6 months)
* Corrected monocular visual acuity \> 5/10
* Possible understanding of experimental conditions
* Patient being able to be quiet and sit during at least 2 hours
* Having given written informed consent prior to any procedure related to the study
* Availability for the period of the study
* Covered by a Health System where applicable, and/or in compliance with the recommendations of the national laws in force relating to biomedical research

Exclusion Criteria

* Ophthalmologic criteria : monocular visual acuity \< 4/10, strabismus , diplopia , ocular instability , nystagmus, maculopathy , glaucoma , retinopathy , orthoptic rehabilitation
* Neurologic criteria : sever phasic disturbances , neurologic degenerative affection , non controlled seizure , severe handicap non compatible with prolonged sit position or concentration during 30 consecutive minutes
* No command of french language
* Non stabilized medical situation
* Females who are pregnant, nursing, or planning a pregnancy during the study period, or females of childbearing potential, not using a reliable means of contraception.
* Not under any administrative or legal supervision
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospices Civils de Lyon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sophie Jacquin-Courtois, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Service de Médecine Physique et de Réadaptation

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de Médecine Physique et de Réadaptation,Hôpital Henry Gabrielle

Saint-Genis-Laval, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ong YH, Jacquin-Courtois S, Gorgoraptis N, Bays PM, Husain M, Leff AP. Eye-Search: A web-based therapy that improves visual search in hemianopia. Ann Clin Transl Neurol. 2015 Jan;2(1):74-8. doi: 10.1002/acn3.154. Epub 2014 Nov 27.

Reference Type BACKGROUND
PMID: 25642437 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A00702-37

Identifier Type: OTHER

Identifier Source: secondary_id

2010.615

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Home-based Vision Therapy
NCT06886737 RECRUITING PHASE1
Visual Rehabilitation After Occipital Stroke
NCT04798924 ACTIVE_NOT_RECRUITING NA
Visual Restoration for Hemianopia
NCT03350919 COMPLETED NA